# Allergy Relief

NDC: 50804-840
Generic name: Loratadine
Labeler / Manufacturer: GOODSENSE
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20181201
Marketing ended: 20260731
FDA application: ANDA206214

## Active ingredients

- LORATADINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50804-840"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50804-840
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=969b7d4b-fb07-4f44-af71-3e5eed922793